News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
579,493 Results
Type
Article (19050)
Company Profile (166)
Press Release (560203)
Multimedia
Podcasts (77)
Webinars (13)
Section
Business (198389)
Career Advice (701)
Deals (30740)
Drug Delivery (86)
Drug Development (65638)
Employer Resources (54)
FDA (12399)
Job Trends (11096)
News (287874)
Policy (24157)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (813)
Accelerated approval (39)
ADA (26)
Adcomms (10)
Allergies (138)
Alliances (41817)
ALS (140)
Alzheimer's disease (1258)
Antibody-drug conjugate (ADC) (334)
Approvals (12989)
Artificial intelligence (492)
ASCO (219)
Autoimmune disease (238)
Automation (39)
Bankruptcy (319)
Best Places to Work (8368)
BIO (47)
BIOSECURE Act (10)
Biosimilars (183)
Biotechnology (103)
Bladder cancer (149)
Brain cancer (55)
Breast cancer (591)
Cancer (4373)
Cardiovascular disease (343)
Career advice (605)
Career pathing (13)
CAR-T (212)
CDC (8)
Celiac Disease (1)
Cell therapy (598)
Cervical cancer (41)
Clinical research (58715)
Collaboration (1662)
Commercialization (1)
Company closure (1)
Compensation (1413)
Complete response letters (59)
COVID-19 (1278)
CRISPR (81)
C-suite (1001)
Cystic fibrosis (123)
Data (6461)
Decentralized trials (1)
Denatured (23)
Depression (123)
Dermatology (66)
Diabetes (433)
Diagnostics (4775)
Digital health (43)
Diversity (3)
Diversity, equity & inclusion (16)
Drug discovery (253)
Drug pricing (126)
Drug shortages (15)
Duchenne muscular dystrophy (222)
Earnings (80632)
Editorial (25)
Employer branding (5)
Employer resources (50)
Events (99051)
Executive appointments (935)
FDA (15434)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (27)
Funding (1184)
Gene editing (161)
Generative AI (35)
Gene therapy (450)
GLP-1 (667)
Government (2005)
Grass and pollen (5)
Guidances (329)
Healthcare (11026)
Hematology (128)
HIV (52)
Huntington's disease (28)
IgA nephropathy (94)
Immunology and inflammation (165)
Immuno-oncology (74)
Indications (188)
Infectious disease (1507)
Inflammatory bowel disease (172)
Inflation Reduction Act (9)
Influenza (96)
Intellectual property (287)
Interviews (93)
IPO (13965)
IRA (33)
Job creations (3104)
Job search strategy (549)
JPM (29)
Kidney cancer (18)
Labor market (39)
Layoffs (250)
Leadership (10)
Legal (6586)
Liver cancer (54)
Longevity (21)
Lung cancer (612)
Lymphoma (333)
Machine learning (35)
Management (18)
Manufacturing (871)
Marketing (7)
MASH (161)
Medical affairs (1)
Medical device (9243)
Medtech (9367)
Mergers & acquisitions (17905)
Metabolic disorders (1041)
mRNA (104)
Multiple sclerosis (136)
NASH (15)
Neurodegenerative disease (286)
Neuropsychiatric disorders (68)
Neuroscience (2374)
Neurotech (1)
NextGen: Class of 2026 (3895)
Non-profit (1257)
Now hiring (23)
Obesity (418)
Opinion (156)
Ovarian cancer (172)
Pain (238)
Pancreatic cancer (219)
Parkinson's disease (270)
Partnered (20)
Patents (561)
Patient recruitment (562)
Peanut (39)
People (50541)
Pharmaceutical (45)
Pharmacy benefit managers (23)
Phase 1 (18114)
Phase 2 (25815)
Phase 3 (19150)
Pipeline (7945)
Policy (163)
Postmarket research (2127)
Preclinical (7520)
Press Release (49)
Prostate cancer (230)
Psychedelics (28)
Radiopharmaceuticals (266)
Rare diseases (820)
Real estate (4460)
Recruiting (20)
Regulatory (19570)
Reports (22)
Research institute (953)
Resumes & cover letters (94)
Rett syndrome (40)
RNA editing (12)
RSV (52)
Schizophrenia (143)
Series A (214)
Series B (151)
Service/supplier (4)
Sickle cell disease (95)
Special edition (11)
Spinal muscular atrophy (112)
Sponsored (15)
Startups (2782)
State (2)
Stomach cancer (8)
Supply chain (92)
Tariffs (71)
The Weekly (52)
Vaccines (501)
Venture capital (53)
Weight loss (221)
Women's health (94)
Worklife (4)
Date
Today (58)
Last 7 days (332)
Last 30 days (1388)
Last 365 days (23153)
2026 (12930)
2025 (23303)
2024 (27243)
2023 (31380)
2022 (40749)
2021 (43352)
2020 (39869)
2019 (29710)
2018 (22642)
2017 (24694)
2016 (23541)
2015 (29431)
2014 (25679)
2013 (22085)
2012 (24101)
2011 (24440)
2010 (23672)
Location
Africa (465)
Alabama (76)
Alaska (2)
Arizona (317)
Arkansas (13)
Asia (30074)
Australia (4131)
California (12151)
Canada (3339)
China (991)
Colorado (489)
Connecticut (442)
Delaware (265)
Europe (54484)
Florida (1844)
Georgia (390)
Hawaii (2)
Idaho (49)
Illinois (828)
India (85)
Indiana (539)
Iowa (14)
Japan (537)
Kansas (115)
Kentucky (36)
Louisiana (28)
Maine (27)
Maryland (1307)
Massachusetts (8375)
Michigan (316)
Minnesota (575)
Mississippi (5)
Missouri (99)
Montana (27)
Nebraska (16)
Nevada (114)
New Hampshire (68)
New Jersey (3075)
New Mexico (17)
New York (3001)
North Carolina (1459)
North Dakota (4)
Northern California (6046)
Ohio (287)
Oklahoma (16)
Oregon (27)
Pennsylvania (2330)
Puerto Rico (26)
Rhode Island (35)
South America (731)
South Carolina (78)
South Dakota (1)
Southern California (5001)
Tennessee (139)
Texas (1937)
United States (41204)
Utah (367)
Vermont (1)
Virginia (252)
Washington D.C. (51)
Washington State (949)
West Virginia (2)
Wisconsin (97)
Wyoming (1)
579,493 Results for "lotus pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa
May 6, 2026
·
10 min read
Press Releases
Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas
May 4, 2026
·
9 min read
Press Releases
Alvogen Announces Sale to Lotus, Creating a Leading International Specialized Generics Platform
September 23, 2025
·
3 min read
Business
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co. Ltd. (1975.TW) in Recent Financial Report
NRx Pharmaceuticals, Inc. today announced that its Asia Pacific strategic partner Lotus Pharmaceutical Co. Ltd (1975.TW) identified enrollment completion of the NRx clinical trial in bipolar depression as a material event in is February 7 financial filing.
February 9, 2024
·
3 min read
Business
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance of $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced the advance of the first $5 million milestone payment based on the Company’s partnership agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW).
February 12, 2024
·
3 min read
Business
NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101
Lotus Pharmaceuticals (1795:TT; “Lotus”) and NRx Pharmaceuticals Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals or NRx”), a clinical stage biopharmaceutical company, today announced a global collaboration agreement covering the development and commercialization of NRX-101 for suicidal treatment-resistant bipolar depression (S-TRBD) for global markets.
June 5, 2023
·
11 min read
Press Releases
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
June 28, 2026
·
5 min read
Press Releases
Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
October 29, 2025
·
4 min read
Press Releases
LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia
May 12, 2025
·
4 min read
Press Releases
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
July 15, 2026
·
2 min read
1 of 57,950
Next
